Showing posts with label Science - Health - Research. Show all posts
Showing posts with label Science - Health - Research. Show all posts

Wednesday, 22 April 2026

Science: the mind and imagination

 

How does imagination really work in the brain? New theory upends what we knew

Grandfailure/Getty Images





















Thomas Pace, University of the Sunshine Coast and Roger Koenig-Robert, University of Technology Sydney; UNSW Sydney

Your brain is currently expending about a fifth of your body’s energy, and almost none of that is being used for what you’re doing right now. Reading these words, feeling the weight of your body in a chair – all of this together barely changes the rate at which your brain consumes energy, perhaps by as little as 1%.

The other 99% is used on the activity the brain generates on its own: neurons (nerve cells) firing and signalling to each other regardless of whether you’re thinking hard, watching television, dreaming, or simply closing your eyes.

Even in the brain areas dedicated to vision, the visuals coming in through your eyes shape the activity of your neurons less than this internal ongoing action.

In a paper just published in Psychological Review, we argue that our imagination sculpts the images we see in our mind’s eye by carving into this background brain activity. In fact, imagination may have more to do with the brain activity it silences than with the activity it creates.

Imagining as seeing in reverse

Consider how “seeing” is understood to work. Light enters the eyes and sparks neural signals. These travel through a sequence of brain regions dedicated to vision, each building on the work of the last.

The earliest regions pick out simple features such as edges and lines. The next combine those into shapes. The ones after that recognise objects, and those at the top of the sequence assemble whole faces and scenes.

Neuroscientists call this “feedforward activity” – the gradual transformation of raw light into something you can name, whether it’s a dog, a friend, or both.

In brain science, the standard view is that visual imagination is this original seeing process run in reverse, from within your mind rather than from light entering your eyes.

So, when you hold the face of a friend in mind, you start with an abstract idea of them – a memory or a name, pulled from the filing cabinet of regions that sit beyond the visual system itself.

That idea travels back down through the visual sequence into the early visual areas, which serve as your brain’s workshop where a face would normally be reconstructed from its parts – the curve of a jawline, the specific shade of an eye. These downward signals are called “feedback activity”.

A signal through the static

However, prior research shows this feedback activity doesn’t drive visual neurons to fire in the same way as when you actually see something.

At least in the brain regions early in the vision process, feedback instead modulates brain activity. This means it increases or decreases the activity of the brain cells, reshaping what those neurons are already doing.

Even behind closed eyes, early visual brain areas keep producing shifting patterns of neural activity resembling those the brain uses to process real vision.

Imagination doesn’t need to build a face from scratch. The raw material is already there. In the internal rumblings of your visual areas, fragments of every face you know are drifting through at low volume. Your friend’s face, even now, is passing through in pieces, scattered and unrecognised. What imagining does is hold still the currents that would otherwise carry those pieces away.

All that’s needed is a small, targeted suppression of neurons that are pulled by brain activity in a different direction, and your friend’s face settles out of the noise, like a signal carving its way through static.

Steering the brain

In mice, artificially switching on as few as 14 neurons in a sensory brain region is enough for the animal to notice it and lick a sugar-water spout in response. This shows how small an intervention in the brain can be while still steering behaviour.

While we don’t know how many neurons are needed to steer internal activity into a conscious experience of imagination in humans, growing evidence shows the importance of dampening neural activity.

In our earlier experiments, when people imagined something, the fingerprint it left on their behaviour matched suppression of neuronal activity – not firing. Other researchers have since found the same pattern.

Other lines of evidence strengthen our theory, too. About one in 100 people have aphantasia, which means they can’t form mental images at all. One in 30 form these images so vividly they approach the intensity of images we actually see, known as hyperphantasia.

Research has found that people with weaker mental imagery have more excitable early visual areas, where neurons fire more readily on their own. This is consistent with a visual system whose spontaneous patterns are harder to hold in shape.

Taking all this together, the spontaneous activity reshaping hypothesis – our new theory that imagination carves images out of the steady stream of ongoing brain activity – explains why imagination usually feels weaker than sight. It also explains why we rarely lose track of which is which.

Visual perception arrives with a strength and regularity the brain’s own internal patterns don’t match. Imagination works with those patterns rather than against them, reshaping what is already there into something we can almost see.The Conversation

Thomas Pace, Researcher and Lecturer at the Thompson Institute, University of the Sunshine Coast and Roger Koenig-Robert, Senior Research Fellow, Graduate School of Health, University of Technology Sydney; UNSW Sydney

This article is republished from The Conversation under a Creative Commons license. Read the original article.

Wednesday, 10 April 2024

Cosmetics and fitness exercise: the combination may not work

                                                                                                Shutterstock
 
Cosmetics and fitness training - do they belong together ? Apparently no. There is a certain common sense logic to it - having foundation on the skin while exercising prevents skin pores from opening and releasing sebum. Sebum is a waxy. oily substance produced by the sebaceous glands that protects the health of skin.

A research study from Texas A & M University - San Antonio using a cohort of 43 college students (20 men and 23 women) monitored pore size and sebum production after the use of a skin cleanser and then application of foundation in a single layer on the participants faces.  The participants then ran for 20 minutes on a treadmill after which skin measurements were taken and the level of sebum assessed. Perhaps not surprisingly, it was found that the size of skin pores increased in areas of skin where there was no foundation applied in comparison to where it had been applied. It was concluded that the foundation cosmetic restricted pores from "..naturally enlarging during exercise, prevcenting the release of sebum and sweat, which moisturises and cools the skin" [Journal of Cosmetic Dermatology].

This research is probably not earth shattering in any measure as similar findings have been found for film/television production make-up, large body ink tattooes and body paint which prevents the skin "from breathing". It does however provide a measure of actual evidence to support the perspective that natural appearance is best.

So be safe, be sweaty !

Sunday, 7 April 2024

9,000 to 10,000 steps a day - does it really help with health ?

                                                       Shutterstock
Taking long walks amounting to 10,000 steps has long been cited in the media and in various health related publications as beneficial for reducing heart disease and improving general health, however the origin of this claim and the evidence behind it, has long been a mystery. One suggestion is that the source of this claim comes from a marketing campaign promoting pedometers - which seems very plausible. Specific evidence of the health benefits has been minimal.

One study has now been released by the University of Sydney and published in the British Journal of Sports Medicine. This study involved 72,000 participants with an average age of 61 whom wore a movement tracking accelerometer on their wrists for one week. Over an average of 7 years, these participants were tracked and adjusting for factors relating to illness and death (diet, smoking, other forms of exercise), the optimal number of steps per day for a health benefit were between 9,000 and 10,000. This number of steps was calculated to provide a 39 % lower risk of dying duirng the follow-up period (the 7 years) and a 21 % lower risk of a heart-related incident. Happy walking !

Link to the article: British Journal of Sport Medicine

Sunday, 5 March 2017

CRISPR - genetic engineering has arrived

                                                                                          Shutterstock
The ability to precisely alter, delete and rearrange the DNA of any living organism, including humans - once the realm of science fiction or futurists it has become a reality with the development of the biotechnology known as CRISPR or in its extended form, CRISPR-Cas9. The non abbreviated version is 'clustered regularly interspaced short palindromic repeats' with the Cas9 part referring to a particular enzyme. CRISPR has a number of existing and potential applications such as:
  • disease control and discovering the DNA sequences for viruses, thus opening the way for new treatments.
  • influencing ecology by introducing disease-resistant genes into wild populations of parasitic insects reducing pathogen transmission to humans.
  • adding climate and pest resistant characteristics into food crops.
  • editing hereditary disease susceptible genes in humans.
CRISPR operates by using a cellular scalpel, an enzyme Cas9, to cut DNA. The enzyme is guided to its destination by a RNA guide that ensures that Cas9 cuts out the target nucleotides of DNA allowing the insertion of a different chain of nucleotides which were included in the CRISPR package. The potential changes as a result of this biotechnology are profound and in many cases hard to accurately foresee. Vectors for diseases could be genetically altered and rendered harmless (such as mosquitoes), food crops could be made climate change and pest resistant, threatened species of animals could be made hardier to survive and human hereditary health conditions prevented.

There are also dangers with this biotechnology - the risk of the unknown: for example, inadvertently shifting viruses and other pathogens from one species to another thus creating diseases for which there is no known protection or treatment. But will the advantages gained outweigh the risks ?

Sunday, 12 April 2015

Half a minute past midnight - The threat of antibiotic-resistant superbug bacteria

The threat posed to public health by antibiotic resistant bacteria has been well known since the early 1990s however recent reports in the media of potential discoveries of new drugs has given hope that the threat is being mitigated, if not resolved. This is an unduly optimistic and premature belief.

The recent report on Antimicrobial Resistance (AMR) to the UK Prime Minister in December 2014 highlighted that antimicrobial resistant infections currently claim over 50,000 lives each year across Europe and the United States alone. In 15 European countries more than 10% of bloodstream Staphylococcus aureas infections are now caused by methicillin-resistant strains (or MRSA) with some countries now approaching 50%. Drug-resistant tuberculosis prevalence amounted to 480,000 new cases in 2013 worldwide and reported cases of drug resistant malaria have started increasing in South East Asia particularly in Myanmar and Thailand. The death toll from drug resistant malaria is only available as a vague estimate of between 10,000 and 200,000 people worldwide, mainly children. The tough gut-bacteria known as Enterobacteriaceae of which the best known is Escherichia coli (or E-coli) have also been found to have drug-resistant strains. In the United States, currently 4% of Enterobacteriaceae are drug resistant and in Greece it has reached 68% for the strain of Klebsiella.

Research from the United States has found that drug resistant bacteria from cattle has been able to become airborne and move distances for further contamination.

Without effective prophylactic antibiotics to reduce infections, many surgical procedures would become too risky to undertake. Four areas of high-volume medical intervention would particularly be affected: caesarean sections for births; joint replacements; cancer surgical treatment; and organ transplants. In effect modern medicine would be plunged backwards into the pre-antibiotic period.

In early 2015, the discovery of Teixobactin, a small molecule antibiotic was announced in the journal Nature. Teixobactin was found to effectively kill both Staphylococcus aureas and Mycobacterium tuberculosis without the bacteria developing resistance. However this drug has not yet undergone clinical trials involving humans and is at best 5 to 6 years away from this stage of testing. A newer class of drugs termed carbapenems have been in use but a significant number of these remain suspended from development due to economic and regulatory hurdles. Even so carabapenem-resistant bacteria are on the rise.

And what are the causes of this growing health crisis ? Drug development is less than half the problem with over-prescribing/misuse of antimicrobials, and counterfeit/sub-standard drugs being sold over the counter without a prescription being major culprits, particularly in developing countries such as parts of Africa, India, Pakistan and Bangladesh. Researchers have found drug-resistant Enterobacteriaceae in street puddles in Delhi, India and in water samples taken in Pakistan and Bangladesh. Although infection control in hospitals can provide short term solutions, the fundamental need for new discoveries, faster pathways for antibiotics to be available and stricter management of drug access and use remains the pivotal changes needed.

The link to the research findings for Teixobactin is at the link below:
Nature: Teixobactin

The link to the UK report can be accessed at the link below: